Memorial Sloan Kettering Cancer Center (MSK) today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center. The new building has been thoughtfully designed to meet the growing cancer care needs of the future — including advanced technology to care for patients, leading-edge robotics and a digital infrastructure, as well as enhanced operating and procedure suites.
The Pavilion is named in honor of Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, who made a landmark gift to support clinical innovation at MSK in 2023.
“Ken’s generosity is unparalleled in its impact on our organization and our ability to advance MSK’s mission of ending cancer for life,” said Selwyn M. Vickers, MD, FACS, MSK’s President and CEO. “Through his landmark contribution, Ken is improving the lives of people across New York City and around the world, helping MSK continue providing world-class, leading-edge cancer care as the field advances devoted and the incidence of cancer increases. We are deeply grateful for his exceptional contribution.”
“The extraordinary team at MSK is saving lives every single day, offering not only world-class medical care but also compassion, dignity, and hope to the patients and families facing the challenges of cancer,” said Mr. Griffin. “The new Pavilion ensures that MSK’s physicians, scientists, nurses, and staff have the world-class facilities required to meet the evolving needs of cancer patients. I am honored to support their life-changing work.”
Located on York Avenue between East 66th and East 67th Streets, The Kenneth C. Griffin Pavilion at MSK will be exclusively dedicated to patient care. The Leadership in Energy and Environmental Design (LEED)-certified full-service facility will be built entirely within MSK’s existing footprint, devoted to ensuring greater access to cancer care and meeting the needs of New Yorkers and people from around the globe. A two-story bridge will provide a critical connection to Memorial Hospital between the two buildings and ensure safe and convenient access for patients and staff.
MSK’s additional capacity will serve New Yorkers and patients who choose to travel for lifesaving care. The Kenneth C. Griffin Pavilion at MSK is designed to help meet the growing need for cancer care — the Centers for Disease Control and Prevention estimates that cancer cases will rise by nearly 50% by 2050, which could mean more than 60,000 people diagnosed by that date with the disease in New York City alone. Innovating in care delivery is one of the strategic initiatives supported by The MSK Campaign: Leading Science. Changing Lives. The MSK Campaign aligns with MSK’s 2030 strategic plan and is an opportunity for MSK’s vibrant community to support its mission of ending cancer for life by raising $6 billion by 2030 to shape the future of cancer care. Every day, MSK doctors and scientists bring courage and creativity to answer cancer’s biggest questions, apply discoveries to care, and train the next generation of leaders. Organized across six strategic initiatives, The MSK Campaign ensures MSK will have the resources needed to create new treatments and cures, turning a legacy of innovation into impact for people with cancer around the world. You are invited to join the Campaign and change lives with us.
Learn more about The MSK Campaign at giving.mskcc.org/msk-campaign.
Contact:
Andrea Fassacesia
fassaca1@mskcc.org